Patients taking Pelzont (2000 mg/ 40 mg) with or without a statin, versus placebo, had significantly decreased LDL-C (-18.9% vs. -0.5%), TG (-21.7% vs.
Patsientidel, kes said Pelzont’ i 2000 mg/ 40 mg koos statiiniga või ilma võrreldes platseeboga, ilmnes LDL- kolesterooli (- 18, 9% vs. - 0, 5%), triglütseriidide (- 21, 7% vs.